- [PRESSWIRE] 29 January, 2020 – UK — New research released today reveals that the average football fan in the United States, will eat a staggering 10,821 calories and 180 grams of saturated fat this Super Bowl Sunday.
- [PRESSWIRE] Atlanta, Ga. – 14 gennaio 2020 — Il Team Novo Nordisk, la prima squadra ciclistica professionistica al mondo interamente composta da corridori con diabete, correrà la stagione 2020 su telai Colnago completi di componenti, freni a disco e misuratori di potenza Shimano di2, indossando kit progettati dalla GSG.
- [PRESSWIRE] Atlanta, Ga. – 14 January, 2020 —Team Novo Nordisk, the world’s first all-diabetes pro cycling team, will race the 2020 season on Colnago frames complete with Shimano di2 components, disc brakes, and power meters while wearing GSG-designed kits.
- [PRESSWIRE] UK – 10 January, 2020 — To coincide with Blue Monday on January 20th, electronics retailer Ebuyer has conducted a survey into the link between mental health and online help.
- [PRESSWIRE] Parma – December 19, 2019 — The 2017 Annual Report of the ERA-EDTA Registry [1] reveals that only a small fraction of patients accepted for renal replacement therapy are able to start this treatment with the best available therapy, which is transplantation, – and that the number of people who are in need of renal replacement therapy is rising. This poses a major challenge to our health systems, therefore everything should be done to fight this trend, e.g. by strengthening prevention.
- [PRESSWIRE] Parma, November – 18, 2019 — High protein intake is believed to be healthy, but it may pave the way to irreversible kidney failure. The risk of the kidneys being harmed by a diet rich in proteins is especially high in people with a pre-existing low-grade chronic kidney disease, of which most of the affected people are unaware. “It is essential that people know there is another side to high-protein diets.”
- [PRESSWIRE] BOSTON, Nov. 18, 2019 — Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has been selected by Novartis, a global healthcare company, to collaborate on a commercial project for managing patients with heart failure (HF) beginning in Southeast Asia, with potential plans to expand globally. The goal of the program is to improve clinical outcomes by using Biofourmis’ lead product BiovitalsHF™, which captures data from wearable biosensors and leverages the FDA-cleared Biovitals™ Analytics Engine to identify early signs of HF exacerbations to enable early interventions in patients with HF with reduced ejection fraction.
- [PRESSWIRE] Parma – November 12, 2019 – Diabetes is one of the key drivers of chronic kidney disease and the most frequent reason why patients are in need of renal replacement therapy. Conversely, outcomes for dialysis patients with diabetes are rather poor. For these reasons, the ERA-EDTA aims to raise awareness of the threat of kidney disease on World Diabetes Day on November 14. It is important to prevent diabetes wherever possible and if not, to take great care to ensure that kidney health is protected in diabetic patients. SGLT2 inhibitors have the potential to treat CKD in patients with diabetes.
- [PRESSWIRE] DENVER, Oct. 24, 2019 — Aspen Laser Systems, LLC, an emerging leader in laser therapy, also referred to as Photobiomodulation, announced that it has been recognized with an award by Global Health & Pharma, a leading publication and information sharing platform, dedicated to the healthcare industry.
- [PRESSWIRE] ITALY – 15 October, 2019 — The 18th Congress of the International Pediatric Nephrology Association (IPNA) will take place in Venice, Italy, from 17-21 October 2019. IPNA’s vision is to achieve optimal care for all children with kidney disease all over the world through advocacy, education, and training in developed countries as well as in under-resourced regions. By means of the Congress and various educational programs, IPNA disseminates knowledge in order to improve the situation of more than 23,000 children on chronic renal replacement therapy.
- [PRESSWIRE] LONDON, July 29, 2019 — In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1% from 2018 to 2029. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.
- [PRESSWIRE] London – 09 July 2019 — The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients. Over 850 million people suffer from kidney diseases worldwide, a number which signifies epidemic proportions, yet these patients are still ignored by investigators and initiators of clinical trials in all medical fields – and are thus excluded from clinical trials. ASN, ERA-EDTA and ISN, collaboratively aim to bring about a paradigm change in medical research and have launched an information campaign to that end.
- [PRESSWIRE] SEATTLE, June 19, 2019 — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, has selected BardyDx to participate in the organization’s 2019 Showcase program, featuring the most promising medical technologies from around the globe.
- [PRESSWIRE] Budapest – June 14, 2019 — Kidney transplantation is the treatment of choice for most people with kidney failure, as it will improve their survival while increasing their quality of life compared to remaining on dialysis.
- [PRESSWIRE] Budapest – June 14, 2019 — In the CARMELINA trial nearly 10% of all patients with diabetes had nephrotic-range proteinuria at baseline. This was associated with a high incidence of cardiovascular/kidney disease but this secondary disease burden could not be lowered by linagliptin.
- [PRESSWIRE] Budapest – June 14, 2019 — 26% of patients had been employed 6 months prior to dialysis initiation – but this dropped to 15% when dialysis treatment was initiated.
- [PRESSWIRE] Budapest, June 14, 2019 – As chronic kidney disease (CKD) progresses, the kidneys become less able to maintain a healthy balance of acids in the body, a condition known as metabolic acidosis.
- [PRESSWIRE] Budapest – June 14, 2019 — Epidemiological and clinical research and public policy in Europe are generally considered to be comprehensive and successful – and the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) is playing a key role in the field of nephrology research.
- [PRESSWIRE] Budapest – June 14, 2019 — Acute kidney injury (AKI) is a common complication after cardiac surgery. The severity fluctuates from subclinical AKI, an increase in biochemical markers of kidney injury, to severe AKI requiring renal replacement therapy with dialysis.
- [PRESSWIRE] Budapest – June 13, 2019 — Alport syndrome (AS) is a hereditary type IV collagen disease that leads to progressive proteinuria, renal fibrosis, and kidney failure.
- [PRESSWIRE] Budapest – June 13, 2019 — High cardiovascular morbidity and mortality remain a persisting problem in patients with CKD. Many efforts have been made in subjects with normal kidney function to prevent and to reduce the progression of cardiovascular diseases.
- [PRESSWIRE] Budapest – June 13, 2019 — Historically, the number of RCTs performed in the ESRD population has been very low compared to other medical subspecialties. Furthermore, several of the few large RCTs conducted in patients with ESRD have yielded inconclusive or negative results, dampening enthusiasm for future investment in similar trials.
- [PRESSWIRE]10 June, 2019 – Vancouver, British Columbia — Harvest One (“Harvest One” or the “Company”) (TSXV: HVT; OTCQX: HRVOF), through it’s wholly-owned subsidiary Satipharm Ltd. (“Satipharm”) today announced that it has entered into an agreement to distribute their proprietary Satipharm CBD 10mg Gelpell® through Holland & Barrett, Europe’s largest retailer of nutritional supplements and wellness products with over 145 years of experience in the health and wellness industry.
- [PRESSWIRE] NETANYA, Israel, June 4, 2019 — Eitan Group, a global leader in advanced infusion therapy solutions across the care continuum, today announced the opening of a new office in Southern California. The new US Headquarters will be based in Aliso Viejo and will be led by Eitan Group North America CEO, Roger Massengale, to support purchasing, training and service-related needs.
- [PRESSWIRE] Hungary – 09 May, 2019 — People go from all parts of the world to Budapest (Hungary, Europe) to get their teeth fixed and save up to 70% on dental care. It is no matter if it is about a complete smile makeover or just some lost teeth should be replaced by implants or a couple of crowns should be fitted, one of the most preferred destinations is Budapest.
- [PRESSWIRE] LAGUNA HILLS, Calif. – May 1, 2019 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and personalized medicine for early stage breast cancer, will present interim results from its large PREDICT study during a poster presentation (Abstract ID: 581643), titled “Interim Analysis of the DCISionRT PREDICT Study: Clinical Utility of a Biologic Signature Predictive of Radiation Therapy (RT) Benefit in Patients with DCIS”, at the American Society of Breast Surgeons (ASBrS) Annual Meeting in Dallas, TX.
- [PRESSWIRE] Parma – April 26, 2019 — The recently published CREDENCE study [1] showed that SGLT2 inhibitors can slow progression of chronic kidney disease (CKD) in diabetes patients in addition to the effects seen with RAAS blockade. The study results were presented at the World Nephrology Congress in Melbourne and showed that Canagliflozin was associated with a 34% risk reduction of the renal end point (end stage renal disease, doubling of serum creatinine or renal death). The previous day, the SONAR study had shown that the selective endothelin A receptor antagonist, atrasentan, reduced the risk of renal events in a specially selected CKD cohort with diabetes to a similar extent (35%).
- [PRESSWIRE] Parma – 18 April 2019 — Kidney transplantation is the best renal replacement therapy available. Although survival and quality of life are significantly better compared to dialysis patients, transplant recipients nevertheless have a significantly higher cardiovascular morbidity and mortality than healthy people. One recently published study [1] shows current data and derives important conclusions for further long-term improvements in outcomes after kidney transplantation – a highly topical issue, especially for cost reasons and in the event of organ or donor scarcity.
- [PRESSWIRE] Parma – 10 April, 2019 — Chronic kidney disease (CKD) is increasingly recognized as a systemic condition. It also impacts upon other organ systems and in recent years much attention has focussed specifically on the link between the kidneys and the heart. There is also an association between brain dysfunction and kidney disease; new data shows that even mild CKD correlates with impairment of cognitive function. A new review by Professor Giovambattista Capasso summarizes the current evidence in this field.
- [PRESSWIRE] CHICAGO, April 9, 2019 — Citizens United for Research in Epilepsy (CURE) announced today the appointment of Beth Lewin Dean, MBA, MPA as the new Chief Executive Officer. Beth brings 17 years of extensive experience within the epilepsy field, which has been driven by her strong commitment to understanding the needs, aspirations and hopes of patients and their loved ones.